Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional paid-in capital	Accumulated Other Comprehensive Loss	Accumulated deficit
Balances at Dec. 31, 2021	$ 160,303	$ 3	$ 342,711	$ (338)	$ (182,073)
Balance at Beginning of period (in shares) at Dec. 31, 2021		25,269,271
Exercise of stock options (in shares)		10,000
Stock-based compensation expense	10,768		10,768
Unrealized loss on available-for-sale securities	(320)			(320)
Issuance of common stock in connection with exercise of pre-funded warrants (In Shares)		12,250,000
Issuance of common stock and pre-funded warrants, net of issuance costs value	60,719	$ 1	60,718
Issuance of common stock in at-the-market offering, net of issuance costs (In Shares)		11,902,500
Issuance of common stock in at-the-market offering, net of issuance costs value	80,847	$ 1	80,846
Issuance of common stock in at-the-market offering, net of issuance costs (In Shares)		4,122,628
Issuance of common stock in at-the-market offering, net of issuance costs value	24,892		24,892
Issuance of common stock under employee stock purchase plan (In Shares)		168,772
Issuance of common stock under employee stock purchase plan value	243		243
Foreign exchange translation adjustment	(164)			(164)
Net Income (Loss)	(60,345)				(60,345)
Balances at Dec. 31, 2022	276,943	$ 5	520,178	(822)	(242,418)
Balance at end of period (in shares) at Dec. 31, 2022		53,723,171
Exercise of stock options	274		274
Exercise of stock options (in shares)		106,176
Vesting of restricted stock (in shares)		50,401
Stock-based compensation expense	25,536		25,536
Unrealized loss on available-for-sale securities	671			671
Issuance of common stock in connection with exercise of pre-funded warrants (In Shares)		4,878,446
Issuance of common stock in at-the-market offering, net of issuance costs (In Shares)		5,659,045
Issuance of common stock in at-the-market offering, net of issuance costs value		$ 1
Issuance of common stock in at-the-market offering, net of issuance costs value	41,611		41,610
Issuance of common stock under employee stock purchase plan (In Shares)		159,480
Issuance of common stock under employee stock purchase plan value	410		410
Foreign exchange translation adjustment	132			132
Net Income (Loss)	(90,210)				(90,210)
Balances at Dec. 31, 2023	$ 255,367	$ 6	$ 588,008	$ (19)	$ (332,628)
Balance at end of period (in shares) at Dec. 31, 2023		64,576,719